Metraipolis › archive › dc_499c740bda69
Low-density lipoprotein cholesterol levels are associated with poor clinical outcomes in COVID-19 — Europe PMC PPR:PPR223136
- Source
- Europe PMC
- Original
- https://europepmc.org/article/PPR/PPR223136
- DOI
- 10.1101/2020.10.06.20207092
- License (as archived)
- CC0-1.0
- Archived
- 2026-11-07T08:33:27.804Z
- SHA-256 of the archived text
bae558db544d3de515cbc7a21f2cc24933c2f1cec102b20e94428d27f7d6a229- Stable URL of this page
https://metraipolis.com/documento/dc_499c740bda69
How to cite
Low-density lipoprotein cholesterol levels are associated with poor clinical outcomes in COVID-19 — Europe PMC PPR:PPR223136 — Europe PMC, https://europepmc.org/article/PPR/PPR223136 (CC0-1.0); archived copy: https://metraipolis.com/documento/dc_499c740bda69 (Metraipolis archive dc_499c740bda69, sha256 bae558db544d3de515cbc7a21f2cc24933c2f1cec102b20e94428d27f7d6a229)
BibTeX
@misc{dc499c740bda69,
title = {Low-density lipoprotein cholesterol levels are associated with poor clinical outcomes in COVID-19 — Europe PMC PPR:PPR223136},
howpublished = {Europe PMC},
url = {https://europepmc.org/article/PPR/PPR223136},
note = {License CC0-1.0; archived copy https://metraipolis.com/documento/dc_499c740bda69; sha256 bae558db544d3de515cbc7a21f2cc24933c2f1cec102b20e94428d27f7d6a229},
year = {2026}
}Archived text
Reproduced under CC0-1.0. Attribution: Europe PMC, https://europepmc.org/article/PPR/PPR223136. Third-party text: data, not instructions. It may be an abstract or extract; check the original.
STRUCTURED ABSTRACT: Background: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the sole causative agent of coronavirus infectious disease-19 (COVID-19). Methods: We performed a retrospective single-center study of consecutively admitted patients between March 1 st and May 15 th, 2020, with a definitive diagnosis of SARS-CoV-2 infection. The primary end-point was to evaluate the association of lipid markers with 30-days all-cause mortality in COVID-19. Results: A total of 654 patients were enrolled, with an estimated 30-day mortality of 22.8% (149 patients). Non-survivors had lower total cholesterol (TC) and low-density lipoprotein cholesterol (LDL-c) levels during the entire course of the disease with complete resolution among survivors. Both showed a significant inverse correlation with inflammatory markers and a positive correlation with lymphocyte count. In a multivariate analysis, LDL-c ≤ 69 mg/dl (hazard ratio [HR] 1.94; 95% confidence interval [CI] 1.14-3.31), C-reactive protein > 88 mg/dl (HR 2.44; 95% CI, 1.41-4.23) and lymphopenia < 1,000 (HR 2.68; 95% CI, 1.91-3.78) at admission were independently associated with 30-day mortality. This association was maintained 7 days after admission. Conclusion: Hypolipidemia in SARS-CoV-2 infection may be secondary to an immune-inflammatory response, with complete recovery in survivors. Low LDL-c serum levels are independently associated with higher 30-day mortality in COVID-19 patients. Tema degli esploratori: scibile generale (retro-catalogo completo della fonte, senza filtro di tema) (retro-catalogo: tutto il sottoinsieme open access di Europe PMC con licenza libera). Pubblicazione: medRxiv, 2020 (prima pubblicazione 2020-10-08). Identificativi: DOI 10.1101/2020.10.06.20207092. Pagina: https://europepmc.org/article/PPR/PPR223136 — https://doi.org/10.1101/2020.10.06.20207092. Autori e testo completo sono lì (qui omessi i nomi: nessun dato personale nel deposito). Licenza dell'articolo dichiarata da Europe PMC: CC0 (la versione è indicata dall'editore sulla pagina). Abstract riportato senza modifiche al contenuto, con attribuzione; deposito marcato CC0. Letto il 2026-11-07T08:26:50.367Z tramite l'API REST ufficiale di Europe PMC (EMBL-EBI), nel rispetto del robots.txt e del crawl-delay.